Plasma sampling

DIAGNOSTIC_TEST3 trials

Sponsors

Eisai Inc., Assistance Publique - Hôpitaux de Paris, Hospital District of Helsinki and Uusimaa

Conditions

Coronary Artery DiseaseCovid-19Critical IllnessHeart Failure NYHA Class IIHeart Failure NYHA Class IIIHeart Failure NYHA Class IVHeart Failure, SystolicHemodynamics

Early Phase 1

Phase 0 Study in Healthy, Hepatic and Renal Impaired Subjects to Obtain Plasma for Lenvatinib Protein Binding

CompletedNCT02998775

Eisai Inc.Hepatic Impairment; Renal Impairment

Start: 2016-12-02End: 2017-07-08Updated: 2018-09-07

Unknown Phase

MIcrovascular Dysfunction in CRitically Ill cOVID-19 Patients

Assistance Publique - Hôpitaux de ParisCovid-19, Critical Illness, Hemodynamics +1

Start: 2021-03-28End: 2022-10-31Target: 40Updated: 2021-04-01

Atrial Appendage Micrograft Transplants to Assist Heart Repair After Cardiac Surgery

RecruitingNCT05632432

Hospital District of Helsinki and UusimaaCoronary Artery Disease, Heart Failure NYHA Class II, Heart Failure NYHA Class III +4

Start: 2024-04-01End: 2026-12-31Target: 50Updated: 2024-04-19

Related Papers

Autologous atrial appendage micrografts transplanted during coronary artery bypass surgery: design of the AAMS2 randomized, double-blinded, and placebo-controlled trial.

2026-01-02